DUBLIN–(BUSINESS WIRE)–The “2023 United States Ambulatory Surgery Center Market Report” report has been added to ResearchAndMarkets.com’s offering.
The in-depth analysis provides invaluable data for 2023, reflecting on the market’s valuation, which currently stands at a robust $43.1 billion. The ASC market’s growth is fueled by multiple factors including the transition from inpatient to outpatient care, tech-driven innovations, and the transformation of hospital outpatient departments (HOPD) into ASC facilities.
Key Findings in the 2023 ASC Market Report:
The report further explores the strategies ASCs are adopting amidst the challenges of staff shortages, such as the implementation of workflow automation and the provision of financial incentives. Single-specialty ASCs, especially those specializing in endoscopy and ophthalmology, remain market leaders, while significant growth is anticipated in orthopedics, cardiovascular, and gastroenterology facilities.
The Future of ASC Efficiency Through Technology
Technology stands at the forefront in transforming the ASC sector. With the integration of artificial intelligence and predictive analytics, ASCs are optimizing operational aspects from scheduling to patient recovery. Innovations such as RFID and EHR platforms tailored to ASCs are proving to be game-changers, propelling efficiency and profitability.
Policy Shifts Affecting the Market Landscape
Policy revisions, such as the loosening of certificate of need (CON) laws, are poised to have a substantial impact on the market with states like Mississippi and North Carolina making decisive moves to facilitate the growth of new ASCs and the conversion from single-specialty to multi-specialty facilities.
The full report encompasses these pivotal market dynamics and equips stakeholders with strategic knowledge crucial for navigating the ASC landscape in 2023 and beyond.
For those looking to gain a comprehensive understanding of the ASC market, this research publication serves as an essential resource. The detailed findings and projections set forth in this report are instrumental for industry professionals, healthcare providers, investors, and policymakers in making informed decisions and charting future courses of action within the ASC market sphere.
For more information about this report visit https://www.researchandmarkets.com/r/iuy04u
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
BELLEVUE, Wash.--(BUSINESS WIRE)--$NVOS #AAPI--Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”) announced today…
GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the…
TraceLink Recognized with Top Honor in Supply Chain Visibility at SupplyTech Breakthrough Awards BOSTON, June 13,…
Meeting will be reconvened on Friday, June 14, 2024 at 10:00 a.m. Eastern Time PHILADELPHIA,…
PBMs are Leeches: First video spot explains pharmacy benefit managers' role in higher drug prices…
Shifting from Task Based to Relationship-Centric Rounding for Enhanced Patient and Workforce Engagement OMAHA, Neb.,…